Alzheimer's disease drug approved in the US despite concerns of clinicians

episode

Health Report - Separate stories podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Trump Makes MAJOR Move as Midterms Get Closer | Guests: Donald & Amy Johnson | 9/29/26 2h 6m · 29 Sep 2026 · The Glenn Beck Program

Best of the Program | Guests: Donald & Amy Johnson | 9/29/26 43 min · 29 Sep 2026 · The Glenn Beck Program

Standoff At Drumcree Enters Third Day 16 min · 29 Sep 2026 · The Last Word with Matt Cooper

The Last Word On Music: Oasis Sell Out Live ’27 Tour In Staggered Three Day Sale 18 min · 29 Sep 2026 · The Last Word with Matt Cooper

The 3 Senate Seats Republicans Can ACTUALLY Flip 1h 2m · 29 Sep 2026 · Next Up with Mark Halperin

Trump Miscalculates as Canada’s PM Carney Plans for US Invasion 16 min · 29 Sep 2026 · Legal AF by MeidasTouch

Report any issue

Source

Recorded21 Jun 2021

Publisherabc.net.au ↗

Handlerec:20488404

Show notes

The US Food and Drug Administration has approved the first drug for Alzheimer's disease in nearly two decades. But not everyone is welcoming the decision. Here in Australia, authorities are considering whether to also give Aducanumab the green light.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related